Mooyoung Jung , Tai-Young Hur , Chan-Lan Kim , Gyeonglim Ryu , Gi-Won Park , Seungmin Ha
{"title":"优化泽西犊牛呼吸道疫苗接种策略:接种时机和母体抗体干扰的影响","authors":"Mooyoung Jung , Tai-Young Hur , Chan-Lan Kim , Gyeonglim Ryu , Gi-Won Park , Seungmin Ha","doi":"10.1016/j.vetimm.2025.110932","DOIUrl":null,"url":null,"abstract":"<div><div>Bovine Respiratory Disease (BRD) poses a significant challenge to the cattle industry, as it causes substantial economic losses and adverse impacts on animal welfare. This study aimed to determine the optimal timing for respiratory vaccination in Jersey calves, considering age-related responses and maternal antibody interference. Twenty-five Jersey calves were randomly assigned to three vaccination groups based on timing: Group A (14 and 16 weeks), Group B (16 and 18 weeks), and Group C (18 and 20 weeks). Calves were further divided into subgroups based on their initial Infectious Bovine Rhinotracheitis (IBR) antibody levels. Blood samples were collected at 8, 14, 24, and 52 weeks of age to measure IBR and Bovine Viral Diarrhea (BVD) antibody levels.</div><div>The results indicated that the vaccination strategy, which considered maternal IBR antibody levels at the time of vaccination, enhanced long-term IBR immunity and influenced BVD immunity. Additionally, calves vaccinated while seronegative for IBR exhibited higher seropositivity at 52 weeks compared to those immunized while seropositive.</div><div>Our findings suggest that the optimal vaccination strategy for Jersey calves involves primary vaccination between 14 and 18 weeks of age, followed by a booster shot at a two-week interval. Furthermore, low maternal anti-IBR antibody levels at the time of vaccination were associated with increased antibody levels at 52 weeks of age and may influence BVD immunity. These findings could inform the development of more effective vaccination strategies for Jersey calves, potentially enhancing BRD management and reducing the economic impact on this breed.</div></div>","PeriodicalId":23511,"journal":{"name":"Veterinary immunology and immunopathology","volume":"283 ","pages":"Article 110932"},"PeriodicalIF":1.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimizing Respiratory Vaccination Strategies for Jersey Calves: Impact of Timing and Maternal Antibody Interference\",\"authors\":\"Mooyoung Jung , Tai-Young Hur , Chan-Lan Kim , Gyeonglim Ryu , Gi-Won Park , Seungmin Ha\",\"doi\":\"10.1016/j.vetimm.2025.110932\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Bovine Respiratory Disease (BRD) poses a significant challenge to the cattle industry, as it causes substantial economic losses and adverse impacts on animal welfare. This study aimed to determine the optimal timing for respiratory vaccination in Jersey calves, considering age-related responses and maternal antibody interference. Twenty-five Jersey calves were randomly assigned to three vaccination groups based on timing: Group A (14 and 16 weeks), Group B (16 and 18 weeks), and Group C (18 and 20 weeks). Calves were further divided into subgroups based on their initial Infectious Bovine Rhinotracheitis (IBR) antibody levels. Blood samples were collected at 8, 14, 24, and 52 weeks of age to measure IBR and Bovine Viral Diarrhea (BVD) antibody levels.</div><div>The results indicated that the vaccination strategy, which considered maternal IBR antibody levels at the time of vaccination, enhanced long-term IBR immunity and influenced BVD immunity. Additionally, calves vaccinated while seronegative for IBR exhibited higher seropositivity at 52 weeks compared to those immunized while seropositive.</div><div>Our findings suggest that the optimal vaccination strategy for Jersey calves involves primary vaccination between 14 and 18 weeks of age, followed by a booster shot at a two-week interval. Furthermore, low maternal anti-IBR antibody levels at the time of vaccination were associated with increased antibody levels at 52 weeks of age and may influence BVD immunity. These findings could inform the development of more effective vaccination strategies for Jersey calves, potentially enhancing BRD management and reducing the economic impact on this breed.</div></div>\",\"PeriodicalId\":23511,\"journal\":{\"name\":\"Veterinary immunology and immunopathology\",\"volume\":\"283 \",\"pages\":\"Article 110932\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary immunology and immunopathology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165242725000522\",\"RegionNum\":3,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary immunology and immunopathology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165242725000522","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Optimizing Respiratory Vaccination Strategies for Jersey Calves: Impact of Timing and Maternal Antibody Interference
Bovine Respiratory Disease (BRD) poses a significant challenge to the cattle industry, as it causes substantial economic losses and adverse impacts on animal welfare. This study aimed to determine the optimal timing for respiratory vaccination in Jersey calves, considering age-related responses and maternal antibody interference. Twenty-five Jersey calves were randomly assigned to three vaccination groups based on timing: Group A (14 and 16 weeks), Group B (16 and 18 weeks), and Group C (18 and 20 weeks). Calves were further divided into subgroups based on their initial Infectious Bovine Rhinotracheitis (IBR) antibody levels. Blood samples were collected at 8, 14, 24, and 52 weeks of age to measure IBR and Bovine Viral Diarrhea (BVD) antibody levels.
The results indicated that the vaccination strategy, which considered maternal IBR antibody levels at the time of vaccination, enhanced long-term IBR immunity and influenced BVD immunity. Additionally, calves vaccinated while seronegative for IBR exhibited higher seropositivity at 52 weeks compared to those immunized while seropositive.
Our findings suggest that the optimal vaccination strategy for Jersey calves involves primary vaccination between 14 and 18 weeks of age, followed by a booster shot at a two-week interval. Furthermore, low maternal anti-IBR antibody levels at the time of vaccination were associated with increased antibody levels at 52 weeks of age and may influence BVD immunity. These findings could inform the development of more effective vaccination strategies for Jersey calves, potentially enhancing BRD management and reducing the economic impact on this breed.
期刊介绍:
The journal reports basic, comparative and clinical immunology as they pertain to the animal species designated here: livestock, poultry, and fish species that are major food animals and companion animals such as cats, dogs, horses and camels, and wildlife species that act as reservoirs for food, companion or human infectious diseases, or as models for human disease.
Rodent models of infectious diseases that are of importance in the animal species indicated above,when the disease requires a level of containment that is not readily available for larger animal experimentation (ABSL3), will be considered. Papers on rabbits, lizards, guinea pigs, badgers, armadillos, elephants, antelope, and buffalo will be reviewed if the research advances our fundamental understanding of immunology, or if they act as a reservoir of infectious disease for the primary animal species designated above, or for humans. Manuscripts employing other species will be reviewed if justified as fitting into the categories above.
The following topics are appropriate: biology of cells and mechanisms of the immune system, immunochemistry, immunodeficiencies, immunodiagnosis, immunogenetics, immunopathology, immunology of infectious disease and tumors, immunoprophylaxis including vaccine development and delivery, immunological aspects of pregnancy including passive immunity, autoimmuity, neuroimmunology, and transplanatation immunology. Manuscripts that describe new genes and development of tools such as monoclonal antibodies are also of interest when part of a larger biological study. Studies employing extracts or constituents (plant extracts, feed additives or microbiome) must be sufficiently defined to be reproduced in other laboratories and also provide evidence for possible mechanisms and not simply show an effect on the immune system.